Adherence to treatment and associated factors in rheumatoid arthritis patients: a cross-sectional study from Iran
The aim of this study is to evaluate adherence to treatment and its related risk factors among a sample of rheumatoid arthritis patients (RA) attending the rheumatology outpatient clinic of Kermanshah university of medical sciences. In this cross-sectional study, RA patients were asked to complete t...
Saved in:
Published in | Reumatismo Vol. 75; no. 1 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Italy
PAGEPress Publications
08.05.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The aim of this study is to evaluate adherence to treatment and its related risk factors among a sample of rheumatoid arthritis patients (RA) attending the rheumatology outpatient clinic of Kermanshah university of medical sciences. In this cross-sectional study, RA patients were asked to complete the Morisky questionnaire and 19-item compliance questionnaire for rheumatology (CQR). Patients were divided into two groups: adherent and non-adherent to treatment, based on the CQR questionnaire results. Demographic and clinical characteristics (age, sex, marital status, education level, economical condition, occupational status, place of residence, underlying diseases, type, and number of drugs) were compared between the two groups to investigate possible risk associations for poor adherence. 257 patients completed the questionnaires (mean age: 43.22, 80.2% female). 78.6% were married, 54.9% were housekeepers, 37.7% had tertiary education, 61.9% had moderate economic status, and 73.2% were residents of an urban area with a large population. Prednisolone was the most commonly used drug followed by non-steroidal anti-inflammatory drugs, sulfasalazine, hydroxychloroquine, and methotrexate. The mean score of the Morisky questionnaire was 5.528 (standard deviation=1.79). 105 patients (40.9%) were adherent to treatment based on the CQR questionnaire. High education level (college or university) was correlated with non-adherence to treatment [27 (25.71%) vs 70 (46.05%), p=0.004]. We concluded that the prevalence of non-adherence to treatment is 59.1% in rheumatoid arthritis patients in Kermanshah, Iran. Having a higher education level is a risk factor for poor treatment adherence. Other variables could not predict treatment adherence. |
---|---|
AbstractList | The aim of this study is to evaluate adherence to treatment and its related risk factors among a sample of rheumatoid arthritis patients (RA) attending the rheumatology outpatient clinic of Kermanshah university of medical sciences. In this cross-sectional study, RA patients were asked to complete the Morisky questionnaire and 19-item compliance questionnaire for rheumatology (CQR). Patients were divided into two groups: adherent and non-adherent to treatment, based on the CQR questionnaire results. Demographic and clinical characteristics (age, sex, marital status, education level, economical condition, occupational status, place of residence, underlying diseases, type, and number of drugs) were compared between the two groups to investigate possible risk associations for poor adherence. 257 patients completed the questionnaires (mean age: 43.22, 80.2% female). 78.6% were married, 54.9% were housekeepers, 37.7% had tertiary education, 61.9% had moderate economic status, and 73.2% were residents of an urban area with a large population. Prednisolone was the most commonly used drug followed by non-steroidal anti-inflammatory drugs, sulfasalazine, hydroxychloroquine, and methotrexate. The mean score of the Morisky questionnaire was 5.528 (standard deviation=1.79). 105 patients (40.9%) were adherent to treatment based on the CQR questionnaire. High education level (college or university) was correlated with non-adherence to treatment [27 (25.71%) vs 70 (46.05%), p=0.004]. We concluded that the prevalence of non-adherence to treatment is 59.1% in rheumatoid arthritis patients in Kermanshah, Iran. Having a higher education level is a risk factor for poor treatment adherence. Other variables could not predict treatment adherence. |
Author | Soufivand, P Assar, S Pournazari, M Mohamadzadeh, D Soleymani, M S |
Author_xml | – sequence: 1 givenname: D surname: Mohamadzadeh fullname: Mohamadzadeh, D email: denamohamadzadeh75@gmail.com organization: Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences. denamohamadzadeh75@gmail.com – sequence: 2 givenname: S surname: Assar fullname: Assar, S email: sh758us@yahoo.com organization: Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences. sh758us@yahoo.com – sequence: 3 givenname: M surname: Pournazari fullname: Pournazari, M email: mehran.pournazari@kums.ac.ir organization: Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences. mehran.pournazari@kums.ac.ir – sequence: 4 givenname: P surname: Soufivand fullname: Soufivand, P email: parvizsoufivand@yahoo.com organization: Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences. parvizsoufivand@yahoo.com – sequence: 5 givenname: M S surname: Soleymani fullname: Soleymani, M S email: Maral_soleymani@yahoo.com organization: Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences. Maral_soleymani@yahoo.com |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37154257$$D View this record in MEDLINE/PubMed |
BookMark | eNpFkctu1DAUhi1URKeFN0DISzaZHl9iJ-yqqsBIlbqBteXYx4yrJJ7azqJvT2amlJUl67_pfFfkYk4zEvKZwVZCx24yLpOtsUxpy4GLLWslvCMbziU0XHXigmwAZNdoKftLclXKE4BSTOsP5FLoVc1bvSHPt36PGWeHtCZaM9o64VypnT21pSQXbUVPg3U15ULjTPP-VJziKsh1n-O6gR7WJautfKOWupxKaQq6GtNsR1rq4l9oyGmiu2znj-R9sGPBT6_vNfn9_f7X3c_m4fHH7u72oXGC89pIPfQiBAesQzGgFmCDV22vUQrvleyYVKzTA2_F0FrJcNAewHvnO8V9UOKa7M65Ptknc8hxsvnFJBvN6SPlP2bdH92IpocguAWuAIIcBuyd6IZe9YBcOhHaNevrOeuQ0_OCpZopFofjaGdMSzG8Y6xVWsFRKs_S0xkyhrdqBuYIzvwHZ47gzBHcavvy2rAME_o30z9S4i9iMZqg |
Cites_doi | 10.1056/NEJMra050100 10.1586/eci.12.23 10.3899/jrheum.081204 10.4078/jrd.2018.25.1.47 10.1001/jama.2018.13103 10.1097/NOR.0b013e3181e5c2c9 10.3390/medicina56040178 10.2147/PPA.S363477 10.1093/rheumatology/kes279 10.1136/annrheumdis-2021-221163 10.1371/journal.pone.0187139 10.1007/s12325-016-0441-3 10.1002/acr.21641 10.2147/PPA.S291983 10.1002/art.39480 10.1136/rmdopen-2017-000585 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 DOA |
DOI | 10.4081/reumatismo.2023.1540 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2240-2683 |
ExternalDocumentID | oai_doaj_org_article_90f32a02600f4bbe9c38b9690e24c3f5 10_4081_reumatismo_2023_1540 37154257 |
Genre | Journal Article |
GeographicLocations | Iran |
GeographicLocations_xml | – name: Iran |
GroupedDBID | --- 2WC 5VS 67V 7X7 8FI ABUWG ADBBV AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS BAWUL BCNDV BENPR CGR CUY CVF DIK EBD ECM EIF EMOBN F5P FRP FYUFA GROUPED_DOAJ KQ8 M~E NPM OK1 PIMPY RNS SV3 UKHRP AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c322t-47b93ffc018e3be730afd6597e43dd648146187b253b5a41eb7d00ddcd862df63 |
IEDL.DBID | DOA |
ISSN | 0048-7449 |
IngestDate | Tue Oct 22 15:10:22 EDT 2024 Fri Aug 16 23:45:23 EDT 2024 Fri Aug 23 04:00:09 EDT 2024 Sat Sep 28 08:14:35 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c322t-47b93ffc018e3be730afd6597e43dd648146187b253b5a41eb7d00ddcd862df63 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-7278-492X 0000-0002-1240-3240 |
OpenAccessLink | https://doaj.org/article/90f32a02600f4bbe9c38b9690e24c3f5 |
PMID | 37154257 |
PQID | 2811567605 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_90f32a02600f4bbe9c38b9690e24c3f5 proquest_miscellaneous_2811567605 crossref_primary_10_4081_reumatismo_2023_1540 pubmed_primary_37154257 |
PublicationCentury | 2000 |
PublicationDate | 2023-May-08 |
PublicationDateYYYYMMDD | 2023-05-08 |
PublicationDate_xml | – month: 05 year: 2023 text: 2023-May-08 day: 08 |
PublicationDecade | 2020 |
PublicationPlace | Italy |
PublicationPlace_xml | – name: Italy |
PublicationTitle | Reumatismo |
PublicationTitleAlternate | Reumatismo |
PublicationYear | 2023 |
Publisher | PAGEPress Publications |
Publisher_xml | – name: PAGEPress Publications |
References | 3690 3691 3692 3693 3694 3695 3696 3697 3687 3698 3688 3699 3689 3700 3701 3702 |
References_xml | – ident: 3689 doi: 10.1056/NEJMra050100 – ident: 3702 doi: 10.1586/eci.12.23 – ident: 3700 doi: 10.3899/jrheum.081204 – ident: 3695 doi: 10.4078/jrd.2018.25.1.47 – ident: 3690 doi: 10.1001/jama.2018.13103 – ident: 3696 doi: 10.1097/NOR.0b013e3181e5c2c9 – ident: 3699 doi: 10.3390/medicina56040178 – ident: 3694 doi: 10.2147/PPA.S363477 – ident: 3691 doi: 10.1093/rheumatology/kes279 – ident: 3692 doi: 10.1136/annrheumdis-2021-221163 – ident: 3701 doi: 10.1371/journal.pone.0187139 – ident: 3698 doi: 10.1007/s12325-016-0441-3 – ident: 3687 doi: 10.1002/acr.21641 – ident: 3693 doi: 10.2147/PPA.S291983 – ident: 3688 doi: 10.1002/art.39480 – ident: 3697 doi: 10.1136/rmdopen-2017-000585 |
SSID | ssj0066177 |
Score | 2.321882 |
Snippet | The aim of this study is to evaluate adherence to treatment and its related risk factors among a sample of rheumatoid arthritis patients (RA) attending the... |
SourceID | doaj proquest crossref pubmed |
SourceType | Open Website Aggregation Database Index Database |
SubjectTerms | Adherence to treatment Antirheumatic Agents - therapeutic use Arthritis, Rheumatoid - drug therapy Arthritis, Rheumatoid - epidemiology CQR questionnaire Cross-Sectional Studies Female Humans Iran Iran - epidemiology Male Medication Adherence Methotrexate - therapeutic use Morisky questionnaire rheumatoid arthritis |
Title | Adherence to treatment and associated factors in rheumatoid arthritis patients: a cross-sectional study from Iran |
URI | https://www.ncbi.nlm.nih.gov/pubmed/37154257 https://search.proquest.com/docview/2811567605 https://doaj.org/article/90f32a02600f4bbe9c38b9690e24c3f5 |
Volume | 75 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV07T8QwDI4QEwsC8TpeChJrRNq4L7YDgYCBCSS2KKkTHQM9uOv9f5ykd8CAWFirqHE_x7Gd2l8YO88b8GVjUUhAFJBnRtQWQUjvpYMCbWtile9jefcMDy_Fy7ervkJNWKIHTsBdNNKr3ATmK-nBWte0qrYN5XQuh1b5xF6aFctkKu3B5HSqxJYJgS0TmtQ0B-T_LmZuEWLB-Vto_ctVOFqRP5xS5O7_PeCMjud2i20OESMfJ0m32ZrrdtjHGCepUY_3U76qFuemQ24GxB3y4TYd_trx2SRKNH2lAbN-ErmM-MCqOr_khkfRxDyWZoUJI_EsD-0n_J4c2i57vr15ur4Tw-0JoiUj7QVUtlHetzKrnbKOLNl4LCl_cKAQSwhnf1ld2bxQtjCQOVuhlIgtUpKDvlR7bL2bdu6A8dpgW7gqcwBIHt03tiLN0mtVq8DKesTEEj79nkgyNCUXAW79BbcOcOsA94hdBYxXYwPFdXxAiteD4vVfih-xs6WGNJlE-M9hOjddzHVe04IoK0rURmw_qW41lapIANqmDv9DhCO2Eb4p1j_Wx2y9ny3cCcUovT2Ny_ETQtLlwQ |
link.rule.ids | 315,786,790,870,2115,27955,27956 |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adherence+to+treatment+and+associated+factors+in+rheumatoid+arthritis+patients%3A+a+cross-sectional+study+from+Iran&rft.jtitle=Reumatismo&rft.au=Mohamadzadeh%2C+D.&rft.au=Assar%2C+S.&rft.au=Pournazari%2C+M.&rft.au=Soufivand%2C+P.&rft.date=2023-05-08&rft.issn=0048-7449&rft.eissn=2240-2683&rft.volume=75&rft.issue=1&rft_id=info:doi/10.4081%2Freumatismo.2023.1540&rft.externalDBID=n%2Fa&rft.externalDocID=10_4081_reumatismo_2023_1540 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0048-7449&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0048-7449&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0048-7449&client=summon |